Biotricity (BTCY) Stock Price, News & Analysis

Company Overview

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Key Stats

• Today's Range: $0.47 to $0.55
• 50-Day Range: $0.33 to $0.58
• 52-Week Range: $0.19 to $1.02
• Volume: 38,342 shs
• Average Volume: 35,603 shs
• Market Capitalization: $11.96 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

BTCY Stock Analysis - Frequently Asked Questions

How have BTCY shares performed this year?

Biotricity's stock was trading at $0.2899 at the beginning of 2025. Since then, BTCY shares have increased by 65.6% and is now trading at $0.48.
View the best growth stocks for 2025 here.

How were Biotricity's earnings last quarter?

Biotricity, Inc. (NASDAQ:BTCY) posted its quarterly earnings results on Thursday, June, 27th. The company reported ($0.47) EPS for the quarter, missing analysts' consensus estimates of ($0.36) by $0.11. The firm had revenue of $3.18 million for the quarter, compared to the consensus estimate of $3.20 million.

When did Biotricity IPO?

Biotricity (BTCY) raised $15 million in an IPO on Thursday, August 26th 2021. The company issued 5,000,000 shares at a price of $3.00 per share. H.C. Wainwright & Co. served as the underwriter for the IPO.

How do I buy shares of Biotricity?

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Biotricity own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include Transdigm Group (TDG), Taiwan Semiconductor Manufacturing (TSM), Wix.com (WIX), Datadog (DDOG), Quanta Services (PWR), PayPal (PYPL) and Royal Caribbean Cruises (RCL).

Company Calendar

• Last Earnings: 6/27/2024
• Today: 6/17/2025
• Next Earnings (Estimated): 6/25/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:BTCY
• CIK: 1630113
• Web: www.biotricity.com
• Phone: (800) 590-4155
• Fax: N/A
• Employees: 40
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($1.08)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$14.09 million
• Net Margins: -80.42%
• Pretax Margin: -80.42%
• Return on Equity: N/A
• Return on Assets: -188.47%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.23
• Quick Ratio: 0.10

Sales & Book Value

• Annual Sales: $12.06 million
• Price / Sales: 0.99
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($1.30) per share
• Price / Book: -0.37

Miscellaneous

• Outstanding Shares: 24,912,000
• Free Float: 22,075,000
• Market Cap: $11.96 million
• Optionable: Optionable
• Beta: 1.21